These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 15663506)

  • 1. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines in Behçet's disease.
    Sayinalp N; Ozcebe OI; Ozdemir O; Haznedaroğlu IC; Dündar S; Kirazli S
    J Rheumatol; 1996 Feb; 23(2):321-2. PubMed ID: 8882039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
    Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
    Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.
    Mege JL; Dilsen N; Sanguedolce V; Gul A; Bongrand P; Roux H; Ocal L; Inanç M; Capo C
    J Rheumatol; 1993 Sep; 20(9):1544-9. PubMed ID: 8164212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
    Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
    Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Yoon KC; Jeong IY; Park YG; Yang SY
    Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular cytokine environment in active Behçet uveitis.
    Ahn JK; Yu HG; Chung H; Park YG
    Am J Ophthalmol; 2006 Sep; 142(3):429-34. PubMed ID: 16935587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's disease.
    Krause I; Weinberger A
    Curr Opin Rheumatol; 2008 Jan; 20(1):82-7. PubMed ID: 18281862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease.
    Kamoun M; Chelbi H; Houman MH; Lacheb J; Hamzaoui K
    Hum Immunol; 2007 Mar; 68(3):201-5. PubMed ID: 17349875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels of interleukin-18 in patients with diabetic nephropathy.
    Mahmoud RA; el-Ezz SA; Hegazy AS
    Ital J Biochem; 2004 Jul; 53(2):73-81. PubMed ID: 15646011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of TNF-alpha and IL-1 in active Behçet's disease.
    Hamzaoui K; Hamza M; Ayed K
    J Rheumatol; 1990 Oct; 17(10):1428-9. PubMed ID: 2254912
    [No Abstract]   [Full Text] [Related]  

  • 18. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
    Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C; Er H; Türköz Y; Cekmen M
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression.
    Huang TL; Lee CT
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):415-20. PubMed ID: 17610667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.